Mind-body Medicine for Patients With Malignant Hematological Diseases

Universität Duisburg-Essen

Status: Enrolling

Conditions: Hematologic Neoplasms

Treatments: Behavioral: Mind-body medicine group program

Study type: Interventional

Funder types: Other

Identifiers

NCT03735992

RBK02-17-00424

Details and patient eligibility

About

This randomized controlled trial aims to investigate the effectiveness of a mind-body group program as a supprtivemanagement strategy for fatigue in patients with malignant hematological diseases.

Enrollment: 94 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients with malignant hematological diseases in complete remission after primary chemotherapy and/or radiation
• Physical and mental ability to attent 8 of 11 group units

Exclusion criteria

• Chemotherapy, radiation, or rehabilitation programm during the study period
• Pregnancy
• Participation in other studies with behavioral interventions during the study period

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

94 participants in 2 patient groups

Mind-body medicine group program

Experimental group

Description:

Patients recieve an 11-week mind-body medicine group program including elements of mindfullness based stress reduction (MBSR), yoga, and education + treatment as usual.

Treatment:

Behavioral: Mind-body medicine group program

Wait list

No Intervention group

Description:

Treatment as usual.